Codexis, Inc. announced the addition of Dr. Arthur Levin to its Strategic Advisory Board, bringing over 30 years of experience in oligonucleotide development. Dr. Levin, a founding member of ...

today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic Advisory Board (SAB). Dr. Levin is a founding member of Avidity Biosciences, a biopharmaceutical company ...

REDWOOD CITY, Calif. - Codexis , Inc. (NASDAQ: NASDAQ:CDXS), a prominent player in enzymatic solutions for pharmaceutical manufacturing whose stock has surged over 50% in the past year, announced ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic ...